Results 261 to 270 of about 2,029,481 (340)

Leveraging blockchain with zero knowledge proofs in wearable health technologies for personalized healthcare. [PDF]

Sci Rep
Khan AA, Laghari AA, Almansour H, Kumar T, Jaghdam IH, Hajjej F, Mohamed MA.   +6 more
europepmc   +1 more source

Development of a portable information system: connecting palmtop computers with medical records systems and clinical reference resources.

, 1993
R Ram, Bruce Block
openalex   +1 more source

Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick, Nomin Enkhtsetseg, Joseph Sadok, Matheus Mochetti, Annabel Sorby Adams, Jennifer Guo, Cristina Trapaga Hacker, Isabella Gomez Hjerthen, Seungwon Lee, Siddharth Satish, Andrew S. Ham, Justin Hill, Denis Balaban, Kevin Kyle, Rebecca L. Gillani, Marcelo Matiello, Aleksandar Videnovic, Eric C. Klawiter, W. Taylor Kimberly, Farrah J. Mateen   +19 more
wiley   +1 more source

Recommendations to improve race identification in health records: A rapid scoping review. [PDF]

PLoS One
Chow M, Senthinathan A, El-Kotob R, Guilcher SJT.   +3 more
europepmc   +1 more source

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Validity of Using Prescription Medications to Classify Disease - A Retrospective Observational Study Using Routinely Collected Electronic Health Records from the UK. [PDF]

Pragmat Obs Res
Schnier C, Busby J, Sheikh A, Quint JK, Price DB, Heaney LG.   +5 more
europepmc   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

The Socio-Demographic Characteristics of Patients Diagnosed with Prostate Cancer Treated in South Africa's Only Rural Central Hospital in 2020: A Cross-Sectional Study Protocol. [PDF]

Healthcare (Basel)
Ntlongweni X, Nomatshila SC, Chitha WW, Mabunda SA.   +3 more
europepmc   +1 more source

Maternal mortality in the Republic of Cyprus: Insights from population-based observations 2004-2022. [PDF]

Eur J Midwifery
Hadjigeorgiou E, Piri V, Sarantaki A, Tigka M, Diamanti A, Karampas G, Metallinou D.   +6 more
europepmc   +1 more source